One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.

Clinical trial NCT05069714 · COMPLETED

Trial details

NCT number: NCT05069714
Sponsor: Seoul National University Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis Autoimmune Diseases Influenza Vaccine Reaction

Start date: 2021-10-01
Primary completion: 2022-09-30
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.